Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Comp Biochem Physiol B Biochem Mol Biol
2015 Feb 01;180:40-7. doi: 10.1016/j.cbpb.2014.10.003.
Show Gene links
Show Anatomy links
Biological and biochemical properties of two Xenopus laevis N-acetylgalactosaminyltransferases with contrasting roles in embryogenesis.
Voglmeir J
,
Laurent N
,
Flitsch SL
,
Oelgeschläger M
,
Wilson IB
.
???displayArticle.abstract???
The biosynthesis of mucin-type O-linked glycans in animals is initiated by members of the large family of polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts), which play important roles in embryogenesis, organogenesis, adult tissue homeostasis and carcinogenesis. Until now, the mammalian forms of these enzymes have been the best characterized. However, two N-acetylgalactosaminyltransferases (xGalNAc-T6 and xGalNAc-T16) from the African clawed frog (Xenopus laevis), which are most homologous to those encoded by the human GALNT6 and GALNT16 (GALNTL1) genes, were shown to have contrasting roles in TGF-β/BMP signaling in embryogenesis. In this study we have examined these two enzymes further and show differences in their in vivo function during X. laevis embyrogenesis as evidenced by in situ hybridization and overexpression experiments. In terms of enzymatic activity, both enzymes were found to be active towards the EA2 peptide, but display differential activity towards a peptide based on the sequence of ActR-IIB, a receptor relevant to TGF-β/BMP signaling. In summary, these data demonstrate that these two enzymes from different branches of the N-acetylgalactosaminyltransferase do not only display differential substrate specificities, but also specific and distinct expression pattern and biological activities in vivo.
Fig. 1. Biological characterization of Xenopus xGalNAc-T6 and –T16. (A) Expression analysis by in situ hybridization of stage 12 (dorsal view) and stage 24 Xenopus embryos. Whereas xGalNAc-T16 is expressed in the anteriormesoderm and in the deep layer of the lateral neural plate at stage 12 and in anteriorbrain, neural crest mediolateral spinal cord and notochord at stage 24 (see also Herr et al., 2008), GalNAc-T16 is highly expressed in the ectoderm, but excluded from the neuroectoderm at stage 12 and highly expressed in the otic vesicle (ov) and cement gland (cg) at stage 24. Paraffin sections, at the indicated positions of the stage 24 and stage 12 embryos stained for xGalNAc-T6 mRNA, are shown below. (B) RT-PCR analysis of stage 20 ectodermal explants isolated from embryos microinjected four times animally at the 4–8 cell stage with 20 pg noggin mRNA, 100 pg op-1 mRNA or both. The expression of six3 and ncad indicated neuralization of the explants, xvent-2 was used as a marker for active BMP signaling, a-actin as a marker for mesoderm and odc as a loading control. (C) Typical phenotypes of untreated Xenopus embryos and embryos microinjected twice dorsal-animally at the 4–8 cell stage with 400 pg mRNA encoding xGalNAc-T6 or xGalNAc-T16. All microinjection experiments were performed at least three times (n > 25) with > 70% of the embryos displaying an reduction of head and eye structures after overexpression of GalNAc-T6 or a expansion of anterior structures, in particular of the cement gland, after GalNAc-T16 injections as described by Herr et al. (2008).
Fig. 2. Activity of frog xGalNAc-T6 and âT16 towards the EA2 and ActR-IIB peptides. A: The activities of the xGalNAc-T6 (after 30 and 60 min; 3.6 μg protein) and -T16 (after 2 and 4 h; 13.4 μg protein) were tested in vitro towards the EA2 peptide and products were identified by either RP-HPLC as evidenced by the appearance of a peak of lower retention time; the inset is of an anti-FLAG Western blot of the two enzyme preparations. B: Incubations of xGalNAc-T6 and -T16 with the ActR-IIB peptide were analysed by MALDI-TOF MS (lower panel; products with m/z 1768 and 1972); significant activity (ca. 10% conversion; m/z 1769) was observed only with xGalNAc-T16, but traces of singly- and doubly-glycosylated products were observed with xGalNAc-T6 (products of m/z 1768 and 1972 were observed with a magnified scaling factor of 500).
Fig. 3. Tandem mass spectrometric analysis of xGalNAcT products. A modified form of the EA2 peptide was employed in a MALDI-ToF-based assay and the fragmentation patterns of the substrate (A; m/z 1345), the mono- and di-glycosylated products of xGalNAc-T6 (B and C; m/z 1548 and 1751) and the sole product of xGalNAc-T16 (m/z 1548) were compared after overnight incubation. Series of putative y-fragments are annotated with amino acids (one-letter code) commencing with the C-terminal arginine residue (y1 ion of 175); a mass difference of 304 corresponds to a glycosylated threonine, whereas mass differences of â 17 may result from loss of ammonia from y-ions. The sequences of the glycosylated peptides are shown with the putatively-modified threonines indicated with asterisks.
Fig. 4. Biochemical characterization of frog xGalNAc-T6 and -T16. The following parameters were measured for both enzymes using the EA2 peptide: (A) temperature optimum, (B) cation dependence and (C) pH optimum. The conditions of time and enzyme dilution were shown for both enzymes to result in the transfer of a single GalNAc residue.
Fig. 5. A phylogeny of polypeptide-modifying N-acetylgalactosaminyltransferases. The NCBI databank was searched for frog, fish, chicken, bovine, murine and human homologues of GalNAc-T1 through to -T20; frog orthologues of the human T5, T8, T18 and T20 as well as mouse and chicken homologues of T8 were not found in this search. Highlighted are the T6 and T16 groups which are the focus of the current study.
Bennett,
Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
2012, Pubmed
Bennett,
Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
2012,
Pubmed
Bennett,
Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy.
1999,
Pubmed
Boskovski,
The heterotaxy gene GALNT11 glycosylates Notch to orchestrate cilia type and laterality.
2013,
Pubmed
,
Xenbase
Breton,
Structures and mechanisms of glycosyltransferases.
2006,
Pubmed
Brunner,
Comparative characterisation of recombinant invertebrate and vertebrate peptide O-Xylosyltransferases.
2006,
Pubmed
Cheng,
Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T15.
2004,
Pubmed
Cottrell,
Polypeptide N-acetylgalactosaminyltransferase activity in tracheal epithelial microsomes.
1992,
Pubmed
Dereeper,
Phylogeny.fr: robust phylogenetic analysis for the non-specialist.
2008,
Pubmed
Elhammer,
Purification and characterization of UDP-N-acetylgalactosamine: polypeptide N-acetylgalactosaminyltransferase from bovine colostrum and murine lymphoma BW5147 cells.
1986,
Pubmed
Freire,
Characterization of a UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase with an unusual lectin domain from the platyhelminth parasite Echinococcus granulosus.
2004,
Pubmed
Freire-de-Lima,
Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process.
2011,
Pubmed
Fritz,
Dynamic association between the catalytic and lectin domains of human UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase-2.
2006,
Pubmed
Fritz,
The beginnings of mucin biosynthesis: the crystal structure of UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase-T1.
2004,
Pubmed
Gao,
YND1, a homologue of GDA1, encodes membrane-bound apyrase required for Golgi N- and O-glycosylation in Saccharomyces cerevisiae.
1999,
Pubmed
Gerken,
The lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylation.
2013,
Pubmed
Guerardel,
O-glycan variability of egg-jelly mucins from Xenopus laevis: characterization of four phenotypes that differ by the terminal glycosylation of their mucins.
2000,
Pubmed
,
Xenbase
Hagen,
cDNA cloning and expression of a family of UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase sequence homologs from Caenorhabditis elegans.
1998,
Pubmed
Hagen,
Purification, cloning, and expression of a bovine UDP-GalNAc: polypeptide N-acetyl-galactosaminyltransferase.
1993,
Pubmed
Hansen,
Prediction of O-glycosylation of mammalian proteins: specificity patterns of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase.
1995,
Pubmed
Herr,
Regulation of TGF-(beta) signalling by N-acetylgalactosaminyltransferase-like 1.
2008,
Pubmed
,
Xenbase
Kong,
Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis.
2015,
Pubmed
Kudo,
Cloning and expression of an alpha-2,8-polysialyltransferase (STX) from Xenopus laevis.
1998,
Pubmed
,
Xenbase
Lang,
Gel-forming mucins appeared early in metazoan evolution.
2007,
Pubmed
,
Xenbase
Li,
Characterization of ppGalNAc-T18, a member of the vertebrate-specific Y subfamily of UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases.
2012,
Pubmed
McGuire,
Enzymatic synthesis of the protein-hexosamine linkage in sheep submaxillary mucin.
1967,
Pubmed
Mendicino,
Purification and characterization of UDP-GalNAc:polypeptide N-acetylgalactosaminyl transferase from swine trachea epithelium.
1998,
Pubmed
Mucha,
Two closely related forms of UDP-GlcNAc: alpha6-D-mannoside beta1,2-N-acetylglucosaminyltransferase II occur in the clawed frog Xenopus laevis.
2002,
Pubmed
,
Xenbase
Mucha,
Tissues of the clawed frog Xenopus laevis contain two closely related forms of UDP-GlcNAc:alpha3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.
2001,
Pubmed
,
Xenbase
Nakamura,
Characterization of a novel polypeptide N-acetylgalactosaminyltransferase (dGalNAc-T3) from Drosophila.
2004,
Pubmed
Nemčovičová,
Characterisation of class I and II α-mannosidases from Drosophila melanogaster.
2013,
Pubmed
O'Connell,
The influence of flanking sequence on the O-glycosylation of threonine in vitro.
1992,
Pubmed
Park,
Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.
2011,
Pubmed
Pedersen,
Low density lipoprotein receptor class A repeats are O-glycosylated in linker regions.
2014,
Pubmed
,
Xenbase
Peng,
Identification of a novel human UDP-GalNAc transferase with unique catalytic activity and expression profile.
2010,
Pubmed
Pratt,
Deconvoluting the functions of polypeptide N-alpha-acetylgalactosaminyltransferase family members by glycopeptide substrate profiling.
2004,
Pubmed
Raman,
UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases: completion of the family tree.
2012,
Pubmed
Schwientek,
Functional conservation of subfamilies of putative UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferases in Drosophila, Caenorhabditis elegans, and mammals. One subfamily composed of l(2)35Aa is essential in Drosophila.
2002,
Pubmed
Steentoft,
Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology.
2013,
Pubmed
Sugiura,
Purification and characterization of UDP-GalNAc:polypeptide N-acetylgalactosamine transferase from an ascites hepatoma, AH 66.
1982,
Pubmed
Takeuchi,
Role of glycosylation of Notch in development.
2010,
Pubmed
Ten Hagen,
Cloning and expression of a novel, tissue specifically expressed member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family.
1998,
Pubmed
Ten Hagen,
Cloning and characterization of a ninth member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family, ppGaNTase-T9.
2001,
Pubmed
Ten Hagen,
A UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase is essential for viability in Drosophila melanogaster.
2002,
Pubmed
Ten Hagen,
All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.
2003,
Pubmed
Ten Hagen,
Characterization of a UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase that displays glycopeptide N-acetylgalactosaminyltransferase activity.
1999,
Pubmed
Topaz,
Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis.
2004,
Pubmed
Tran,
Multiple members of the UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase family are essential for viability in Drosophila.
2012,
Pubmed
Voglmeir,
XT-II, the second isoform of human peptide-O-xylosyltransferase, displays enzymatic activity.
2007,
Pubmed
Wang,
Purification and characterization of a UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase specific for glycosylation of threonine residues.
1992,
Pubmed
Wilson,
Amino acid distributions around O-linked glycosylation sites.
1991,
Pubmed
Wilson,
Induction of epidermis and inhibition of neural fate by Bmp-4.
1995,
Pubmed
,
Xenbase
Wilson,
The never-ending story of peptide O-xylosyltransferase.
2004,
Pubmed
Wu,
Mechanisms of pH regulation in the regulated secretory pathway.
2001,
Pubmed
Zachara,
Cell signaling, the essential role of O-GlcNAc!
2006,
Pubmed
Zimmerman,
The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4.
1996,
Pubmed
,
Xenbase
